Loading...
XSTOSCIB
Market cap8mUSD
Dec 23, Last price  
0.42SEK
1D
-0.48%
1Q
1.96%
Jan 2017
-97.78%
IPO
-99.14%
Name

SciBase Holding AB (publ)

Chart & Performance

D1W1MN
XSTO:SCIB chart
P/E
—
P/S
3.93
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
30.53%
Rev. gr., 5y
27.50%
Revenues
23m
+29.93%
097,0001,600,0004,151,0006,436,0006,859,0006,899,0009,276,0009,521,00011,727,00017,890,00023,245,000
Net income
-56m
L+39.31%
-40,964,393-79,502,000-38,755,000-41,532,000-53,086,000-42,464,000-44,215,000-39,539,000-34,989,000-41,690,000-39,899,000-55,585,000
CFO
-52m
L+16.91%
-36,437,540-34,026,000-37,077,000-46,588,000-47,850,000-44,180,000-37,482,000-37,956,000-33,861,000-39,501,000-44,466,000-51,984,000
Earnings
Feb 19, 2025

Profile

SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
URL
https://www.scibase.com
IPO date
Jun 02, 2015
Employees
22
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
23,245
29.93%
17,890
52.55%
11,727
23.17%
Cost of revenue
77,116
64,277
53,983
Unusual Expense (Income)
NOPBT
(53,871)
(46,387)
(42,256)
NOPBT Margin
Operating Taxes
(3,275)
(88)
Tax Rate
NOPAT
(53,871)
(43,112)
(42,168)
Net income
(55,585)
39.31%
(39,899)
-4.30%
(41,690)
19.15%
Dividends
Dividend yield
Proceeds from repurchase of equity
79,602
71,214
BB yield
-88.39%
-19.96%
Debt
Debt current
2,618
2,910
2,505
Long-term debt
10,976
13,334
3,217
Deferred revenue
Other long-term liabilities
(1,000)
(1,000)
Net debt
(20,527)
(2,588)
(59,885)
Cash flow
Cash from operating activities
(51,984)
(44,466)
(39,501)
CAPEX
(383)
(381)
(617)
Cash from investing activities
(383)
(381)
(526)
Cash from financing activities
67,681
(2,479)
64,217
FCF
(54,835)
(49,587)
(41,195)
Balance
Cash
34,121
18,832
65,607
Long term investments
Excess cash
32,959
17,938
65,021
Stockholders' equity
(662,380)
(611,762)
(566,811)
Invested Capital
712,233
644,666
640,130
ROIC
ROCE
EV
Common stock shares outstanding
107,980
70,546
64,637
Price
0.83
-78.17%
3.82
-30.80%
5.52
19.48%
Market cap
90,055
-66.58%
269,487
-24.47%
356,795
139.59%
EV
69,528
267,627
297,030
EBITDA
(50,483)
(42,736)
(39,304)
EV/EBITDA
Interest
367
5
3
Interest/NOPBT